Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.25.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive (in shares).

 

 

 

Three months Ended March 31,

 

 

2025

 

 

2024

 

Stock options

 

 

4,640,782

 

 

 

5,331,551

 

Warrants

 

 

4,625,000

 

 

 

4,732,391

 

Convertible notes

 

 

176,868,647

 

 

 

102,878,549

 

Total anti-dilutive instrument

 

 

186,134,429

 

 

 

112,942,491